Doctors At Mayo Clinic Using Viruses To Fight Cancer


THAT BLOWBACK AROUND. Reporter: — FIREFIGHTERS SUFFERED MINOR INJURIES. ALL THREE HAVE BEEN RELEASED. MAYO CLINIC DOCTORS ARE USING DEADLY VIRUSES TO FIGHT A DEADLY DISEASE. THE FDA GAVE RIGHT THROUGH STATUS THAT USES THE POLIOVIRUS TO COMBAT CANCEROUS TUMORS. AFTER VISITING THE MAYO CLINIC WE’RE LEARNING THAT DOCTORS ARE SEEING A PROMISING FUTURE TREATING CANCER WITH THE VIRUS. I AM GLAD I ACTUALLY GET TO PARTICIPATE IN THE FRONT PART OF IT TO SEE IF IT’S GOING TO WORK. Reporter: RENEE MALAISE HE WAS DIAGNOSED WITH STAGE III OVARIAN CANCER IN 2014. THE MOTHER OF FIVE WENT THROUGH SURGERY AND 18 ROUNDS OF CHEMOTHERAPY. I WAS DOING WELL UNTIL NOVEMBER I WAS DOING WELL UNTIL NOVEMBER 2015 AND THE CANCER CAME BACK. Reporter: MAYO CLINIC DOCTORS APPROVED OR FOR A CANCER TREATMENT UNLIKE ANY OTHER. WE HAVE ONE OF THE OLDEST PROGRAMS NOT JUST IN THIS COUNTRY BUT IN THE WORLD. Reporter: THE VIRUS THERE. PROGRAM STARTED IN 1994. IT USES A NUMBER OF VIRUSES TO ATTACK CANCER CELLS. DOCTORS ARE USING THE MEASLES VIRUS TO ATTACK OVARIAN CANCER. MY FIRST THOUGHT IS AM I GOING TO GET MEASLES? AT THE END, IF YOU HAVE CANCER, WHO CARES IF YOU HAVE MEASLES? Reporter: DOCTORS GENETICALLY MODIFIED VIRUSES BY INSERTING ANOTHER PIECE OF GENETIC MATERIAL. THIS INCREASES THE THERAPEUTIC EFFECT. CELLS LIKE A TROJAN HORSE CAN CARRY THE VIRUS TO WHERE THE TUMOR IS. Reporter: DR. GOLOTA SAYS THE VIRUS INCREASES THE IMMUNE RESPONSE AGAINST THE TUMOR WHEN IT REPLICATES CANCER CELLS. THE HOPE IS THAT THE TUMORS WIPED OUT COMPLETELY. DOCTORS HOPE MORE OF THESE TREATMENTS WILL BE APPROVED BY THE FDA. I’M CONVINCED THE CORRECT STEPS HAVE BEEN MADE IN THIS DIRECTION AND IN I’VE YEARS WE’RE GOING TO HAVE NOT JUST ONE HIM BUT MANY MORE PROJECTS APPROVED FOR CANCER TREATMENT. I HAD SUCH AN AMAZING SUPPORT SYSTEM. Reporter: RENEE IS STILL BEING MONITORED BY HER DR. AND FEEL SUPPORT FROM HER FAMILY AND FRIENDS. I WOULD NOT RECOMMEND HAVING CANCERS — CANCER, BUT THERE ARE WAYS TO GET DO IT. AFTER

Leave a Reply

Your email address will not be published. Required fields are marked *